# SORRENTO THERAPEUTICS INC (SRNE)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/SRNE/

- Reporting holders: 5
- Reported value: $70
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [VSM Wealth Advisory, LLC](https://holderbook.com/funds/2050660-vsm-wealth-advisory-llc/) | $66 | 110,100 | 0.0% | 2 |
| [HUNTINGTON NATIONAL BANK](https://holderbook.com/funds/49205-huntington-national-bank/) | $4 | 5,001 | 0.0% | 25 |
| [Financial Gravity Companies, Inc.](https://holderbook.com/funds/1377167-financial-gravity-companies-inc/) | $0 | 18 | 0.0% | 1 |
| [OAKWORTH CAPITAL, INC.](https://holderbook.com/funds/1588871-oakworth-capital-inc/) | $0 | 350 | 0.0% | 4 |
| [First Command Advisory Services, Inc.](https://holderbook.com/funds/1727336-first-command-advisory-services-inc/) | $0 | 569 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 5 | $70 |
| Q1 2026 | 3 | $380 |
| Q4 2025 | 3 | $82 |
| Q3 2025 | 2 | $20 |
| Q2 2025 | 1 | $6 |
| Q1 2025 | 1 | $4 |
| Q4 2024 | 4 | $66 |
| Q3 2024 | 3 | $287 |
| Q2 2024 | 3 | $826 |
| Q1 2024 | 4 | $704 |
| Q4 2023 | 6 | $13.9K |
| Q3 2023 | 6 | $6.4K |